Ekso Bionics
Richmond, US · Founded 2012 · 108 employees on LinkedIn · 2 known investors
Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
Founders & leadership
JF
John F. Glennprincipal financial and accounting officer
JP
Jack Peurachprincipal executive officer
CL
Charles LiNamed on SEC filing
WS
William ShawNamed on SEC filing
SS
Stanley SternNamed on SEC filing
JJ
Jason JonesinNamed on SEC filing
TW
Ted WangNamed on SEC filing
TS
Thomas SchreckNamed on SEC filing
MH
Marilyn HamiltonNamed on SEC filing
SS
Steven ShermanNamed on SEC filing
SD
Scott DavisinChief Executive Officer
JW
Jerome WonginChief Financial Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements$103.3M disclosed across 4 of 6 rounds · 2014–2021
▶$3.5MofferedFeb 2021 · 4 investors · BiotechnologyRule 506(b)
▶$3.5MofferedFeb 2021 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jack PeurachExecutive Officer, Director
- Steven ShermanExecutive Officer, Director
- John F. GlennExecutive Officer
- Marilyn HamiltonDirector
- William ShawExecutive Officer
- Stanley SternDirector
- Ted WangDirector
- Thomas SchreckDirector
- Jason JonesExecutive Officer
- Charles LiDirector
- Offering amount
- $3.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5.2MofferedJun 2020 · 7 investors · BiotechnologyRule 506(b)
▶$5.2MofferedJun 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John F. GlennExecutive Officer
- Charles LiDirector
- William ShawExecutive Officer
- Jack PeurachExecutive Officer, Director
- Stanley SternDirector
- Jason JonesExecutive Officer
- Ted WangDirector
- Thomas SchreckDirector
- Marilyn HamiltonDirector
- Steven ShermanExecutive Officer, Director
- Offering amount
- $5.2M
- Sales commissions
- $552.3K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jun 2020
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$22.8MraisedDec 2014 · 157 investors · Other TechnologyRule 506(b)
▶$22.8MraisedDec 2014 · 157 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Russ AngoldExecutive Officer
- Marilyn HamiltonDirector
- Jack PeurachDirector
- Nathan HardingExecutive Officer, Director
- Max Scheder-BieschinExecutive Officer
- Thomas LoobyExecutive Officer
- Daniel BorenDirector
- Steven ShermanDirector
- Offering amount
- $30.3M
- Amount sold
- $22.8M
- Sales commissions
- $1.1M
- Proceeds to insiders
- $2.4M
- Placement agents
- Dinosaur Securities L.L.C., EDI Financial, Inc.
- First sale
- Nov 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$27.4MraisedJan 2014 · 200 investors · Other TechnologyRule 506(b)
▶$27.4MraisedJan 2014 · 200 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Max Scheder-BieschinExecutive Officer
- Daniel BorenDirector
- Russ AngoldExecutive Officer
- Steven ShermanDirector
- Frank MoremanExecutive Officer
- Nathan HardingExecutive Officer, Director
- Jack PeurachDirector
- Marilyn HamiltonDirector
- Offering amount
- $30.3M
- Amount sold
- $27.4M
- Minimum investment
- $5K
- Sales commissions
- $2.2M
- Proceeds to insiders
- $1.9M
- Placement agents
- Dinosaur Securities LLC, EDI Financial, Inc.
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$2.3MraisedJan 2014 · 8 investors · Other TechnologyRule 506(b)
▶$2.3MraisedJan 2014 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BorenDirector
- Jack PeurachDirector
- Max Scheder-BieschinExecutive Officer
- Russ AngoldExecutive Officer
- Frank MoremanExecutive Officer
- Nathan HardingExecutive Officer, Director
- Marilyn HamiltonDirector
- Steven ShermanDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
▶$50.8MraisedJan 2014 · 110 investors · Other TechnologyRule 506(b)
▶$50.8MraisedJan 2014 · 110 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nathan HardingExecutive Officer, Director
- Russ AngoldExecutive Officer
- Steven ShermanDirector
- Marilyn HamiltonDirector
- Max Scheder-BieschinExecutive Officer
- Daniel BorenDirector
- Jack PeurachDirector
- Frank MoremanExecutive Officer
- Offering amount
- $50.8M
- Amount sold
- $50.8M
- First sale
- Jan 2014
- Incorporated
- Corporation, Nevada, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapHypershell Global262 shared keywordsHypershell builds wearable exoskeletons that assist walking, hiking, climbing, and cycling by reducing physical exertion and heart rate over long distances and steep terrain. Its products target outdoor adventurers, hikers, and expedition guides, and it is presented as the first exoskeleton to undergo third-party validation of its performance claims.
German Bionic248 shared keywordsGerman Bionic develops wearable exoskeletons and smart power suits that use AI to assist workers with heavy lifting, prevent posture injuries, and improve workplace safety. The company serves industrial, logistics, healthcare, and airport operations sectors globally.
Hilti214 shared keywordsHilti supplies power tools, fastening and structural connection systems, along with related software and services for professional construction and building trades. Its offerings include cordless power tools, product selector tools, and tool repair tracking for jobsite use.
Companies competing with Ekso Bionics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Ekso Bionics do?
- Ekso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
- Who are Ekso Bionics's investors?
- Ekso Bionics's investors include Emery Capital, Lockheed Martin Ventures.
- How much funding has Ekso Bionics raised?
- Ekso Bionics has disclosed $103.3M raised across 4 of its 6 known rounds.
- Where is Ekso Bionics headquartered?
- Ekso Bionics is headquartered in Richmond, US.




